BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3356290)

  • 21. Structural aspects of human kininogens.
    Muller-Esterl W; Dittmann B; Fritz H; Lottspeich F; Henschen A
    Adv Exp Med Biol; 1983; 156():157-64. PubMed ID: 6552837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma.
    Kerbiriou DM; Griffin JH
    J Biol Chem; 1979 Dec; 254(23):12020-7. PubMed ID: 500690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of human salivary kallikrein: reactivities to human plasma kininogens and proteinase inhibitors.
    Sakamoto W; Yoshikawa K; Uehara S; Nishikaze O
    J Biochem; 1983 Mar; 93(3):833-8. PubMed ID: 6553577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cysteine proteinase inhibitor in the ascitic fluid of sarcoma 180 tumor-bearing mice is a low molecular weight kininogen. Partial NH2- and COOH-terminal sequences and susceptibility to various glandular kallikreins.
    Sueyoshi T; Uwani M; Itoh N; Okamoto H; Muta T; Tokunaga F; Takada K; Iwanaga S
    J Biol Chem; 1990 Jun; 265(17):10030-5. PubMed ID: 2351646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functionally active high molecular weight-kininogen was found in the liver, but not in the plasma of brown Norway Katholiek rat.
    Hayashi I; Maruhashi J; Oh-ishi S
    Thromb Res; 1989 Oct; 56(2):179-89. PubMed ID: 2617467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significant reduction of high molecular weight-kininogen in synovial fluid of patients with active rheumatoid arthritis.
    Sawai K; Niwa S; Katori M
    Adv Exp Med Biol; 1979; 120B():195-202. PubMed ID: 517234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A convenient large-scale preparation of high molecular weight kininogen from human plasma.
    Dittmann B; Steger A; Wimmer R; Fritz H
    Hoppe Seylers Z Physiol Chem; 1981 Jul; 362(7):919-27. PubMed ID: 7275013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinin release from kininogens by calpains.
    Higashiyama S; Ishiguro H; Ohkubo I; Fujimoto S; Matsuda T; Sasaki M
    Life Sci; 1986 Nov; 39(18):1639-44. PubMed ID: 3022089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between the cysteine-proteinase-inhibitory function of rat T kininogen and the release of immunoreactive kinin upon trypsin treatment.
    Moreau T; Gutman N; el Moujahed A; Esnard F; Gauthier F
    Eur J Biochem; 1986 Sep; 159(2):341-6. PubMed ID: 3530756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The kinin released from high molecular weight-kininogen is responsible for inflammatory exudation in rats: detection of kinin-free-kininogen in the exudate by immunoblot analysis.
    Fujie H; Hayashi I; Oh-ishi S
    Life Sci; 1993; 53(22):1691-701. PubMed ID: 8231650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heavy chain of human high molecular weight and low molecular weight kininogens binds calcium ion.
    Higashiyama S; Ohkubo I; Ishiguro H; Sasaki M; Matsuda T; Nakamura R
    Biochemistry; 1987 Nov; 26(23):7450-8. PubMed ID: 3427086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rodent kinin-forming enzyme systems--I. Purification and characterization of plasma kininogen.
    Bedi GS; Balwierczak J; Back N
    Biochem Pharmacol; 1983 Jul; 32(13):2061-9. PubMed ID: 6870934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot-promoting activity.
    Kleniewski J; Donaldson V
    J Exp Med; 1988 Jun; 167(6):1895-907. PubMed ID: 3260266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and characterization of plasma T-kininogen from Wistar and brown Norway rats.
    Adam A; Damas J; Renard C; Calay G; Bourdon V
    Biochem Cell Biol; 1989; 67(2-3):86-92. PubMed ID: 2751876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limited proteolysis of HMW kininogen by plasma kallikrein in man--evidence for a processing mechanism different from the bovine system.
    Müller-Esterl W; Hock H; Rauth G; Kellermann J; Lottspeich F; Henschen A
    Adv Exp Med Biol; 1986; 198 Pt A():97-103. PubMed ID: 3643720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-kinin and T-kininogen--children of new technology.
    Greenbaum LM
    Biochem Pharmacol; 1984 Oct; 33(19):2943-4. PubMed ID: 6487346
    [No Abstract]   [Full Text] [Related]  

  • 37. Quantification of rat T-kininogen using immunological methods. Application to inflammatory processes.
    Adam A; Damas J; Calay G; Renard C; Remacle-Volon G; Bourdon V
    Biochem Pharmacol; 1989 May; 38(10):1569-75. PubMed ID: 2730673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Amino acid and carbohydrate composition and structural features of rabbit high molecular weight kininogen].
    Egorova TP
    Biokhimiia; 1981 Dec; 46(12):2185-92. PubMed ID: 7317538
    [No Abstract]   [Full Text] [Related]  

  • 39. Radioimmunoassay of human high molecular weight kininogen in normal and deficient plasmas.
    Proud D; Pierce JV; Pisano JJ
    J Lab Clin Med; 1980 Apr; 95(4):563-74. PubMed ID: 6153694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Human low molecular weight kininogen: preparation, purification and immunochemical properties].
    Egorova TP; Karpitskiĭ VV; Paskhina TS
    Biokhimiia; 1983 Jul; 48(7):12140-20. PubMed ID: 6412777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.